Physician profile
Elsa Cedillo
NPI 1760840391
$1,857.62
in general payments reported to CMS, 2019-2025
11 companies · $754 in 2025
The $754 reported for 2025 was more than what 83% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $697 · 2024: $406 · 2025: $754.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,673 · Education: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,672.64 |
| Education | $184.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $807.67 | 2023-2025 | |
| Incyte Corporation | $367.18 | 2023-2025 | Opzelura, Opzelura |
| E.R. Squibb & Sons, L.L.C. | $133.52 | 2023 | Sotyktu |
| Amgen INC. | $121.70 | 2025 | |
| Alpha Cognition USA, INC. | $107.27 | 2025 | Zunveyl |
| Pfizer INC. | $93.80 | 2024 | |
| Arcutis Biotherapeutics, INC. | $90.61 | 2024-2025 | Zoryve |
| Sun Pharmaceutical Industries INC. | $86.73 | 2023-2025 | Blu-U, Odomzo, Ilumya |
| Janssen Biotech, INC. | $21.38 | 2023 | Tremfya |
| Hartmann USA, INC. | $17.84 | 2025 | Zetuvit Plus 10x10 P10 |
| Advanced Oxygen Therapy INC. | $9.92 | 2025 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elsa Cedillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.